Bloat Guard

Manufacturer
Phibro Animal Health
Effective date
2019-07-01
Label type
OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-06-01 02:40:27

Label at a glance#

ProductBloat Guard
Active ingredientPOLOXALENE
Label structure7 sections

Dosage and administration

Bloat Guard Liquid Type A Medicated Article must be thoroughly blended and evenly distributed into a liquid feed supplement and offered to cattle in a covered liquid feed supplement feeder with lick wheels. The formula for the liquid feed supplement is as follows: For control of legume (alfalfa, clover, and wheat pasture bloat in cattle…7.5 g/lb %w/w For control of legume (alfalfa, clover) bloat in cattle grazing ...

Storage and handling

At temperatures below 50°F, this product will thicken and may appear cloudy, but is not damaged.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

For use in the manufacture of liquid feed supplements

For control of legume (alfalfa, clover) and wheat pasture bloat in cattle

Active Drug Ingredient

DESCRIPTION SECTION

Poloxalene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99.5%

Inert Ingredients:

SPL UNCLASSIFIED SECTION

Ethoxyquin (a preservative), 0.12%;

butylated hydroxytoluene (a preservative), 0.38%

Follow Directions For Use

DOSAGE & ADMINISTRATION SECTION

Directions for Use in Liquid Feeds

DOSAGE & ADMINISTRATION SECTION

Bloat Guard Liquid Type A Medicated Article must be thoroughly blended and evenly distributed into a liquid feed supplement and offered to cattle in a covered liquid feed supplement feeder with lick wheels. The formula for the liquid feed supplement is as follows:

For control of legume (alfalfa, clover, and wheat pasture bloat in cattle…7.5 g/lb

%w/w

For control of legume (alfalfa, clover) bloat in cattle grazing pre-bloom legumes…10.0 g/lb

% w/w

Poloxalene Type A Medicated Article (99.5%)

1.65

Poloxalene Type A Medicated Article (99.5%)

2.2

Ammonium Polyphosphate

2.66

Ammonium Polyphosphate

2.66

Phosphoric Acid

3.37

Phosphoric Acid

3.37

Sulfuric Acid

1.00

Sulfuric Acid

1.00

Water

10.00

Water

10.00

Molasses, liquid – sufficient to make

100.00

Molasses, liquid – sufficient to make

100.00

Vitamins A&D and/or trace minerals may be added.

Vitamins A&D and/or trace minerals may be added.

The concentration of Bloat Guard per lb of liquid feed supplement is as follows:

Indications for Use

Required Level of Bloat Guard

For control of legume (alfalfa, clover) and wheat pasture bloat in cattle

For control of legume (alfalfa, clover) bloat in cattle grazing pre-bloom legumes

7.5 g/lb (1.65% w/w)

10.0 g/lb (2.2% w/w)

Important:

To maintain proper distribution of Bloat Guard in liquid feed supplements, the viscosity of the medicated liquid supplement must be no less than 275 cps. During storage the medicated liquid may separate out of liquid supplements within 5 days if not agitated. It is essential that all of the stored mixture be thoroughly remixed (for example, by using a recirculating pump) before being transferred to feeders with free-turning lick wheels. Movement of the lick wheels is sufficient to prevent separation in the feeders.

Feeding and Management Directions for Bloat Guard

These medicated supplements are effective for the control of legume (alfalfa, clover) and wheat pasture bloat in cattle, when consumed as recommended.

  • Use a covered liquid feeder with 1 free-turning lick wheel per 25 head at a height so that all cattle can conveniently lick the wheel.
  • The location of the liquid feeder is extremely important for adequate consumption. Place feeder where cattle congregate (for example, near drinking water), thus providing ready access to the medicated liquid feed supplement. In large pastures, additional feeders should be placed so that cattle are never more than 500 feet from a feeder while grazing.
  • For adequate protection, it is essential that each animal consumes the total recommended dosage of medication daily.
  • If grazing on pre-bloom legumes, use a liquid feed supplement containing 10 g of Bloat Guard per lb (2.2% w/w). Each animal must consume the medicated liquid feed supplement at a rate of 0.15 lb per 100 lb of body weight per day for adequate protection. Example: 1.5 lb of 2.2% medicated supplement for a 1000-lb animal daily. If consumption exceeds 0.2 lb per 100 lb of body weight per day, cattle should be changed to a liquid feed supplement containing 7.5 g of Bloat Guard per lb (1.65% w/w).
  • If grazing legumes or wheat pasture, use a liquid feed supplement containing 7.5 g of Bloat Guard per lb (1.65% w/w). Each animal must consume the medicated liquid feed supplement at a rate of 0.2 lb per 100 lb of body weight per day for adequate protection. Example: 2 lb of the 1.65% medicated supplement for a 1000-lb animal daily.
  • Introduce the feeding of the medicated liquid feed supplement at least 2-5 days before pasturing on legume or wheat to accustom the cattle to the medicated liquid supplement and to lick wheel feeding. If the medicated liquid feed supplement feeding is interrupted, this 2-5 day introductory feeding should be repeated.

Cold Weather Note:

STORAGE AND HANDLING SECTION

At temperatures below 50°F, this product will thicken and may appear cloudy, but is not damaged.

Keep Container Closed When Not in Use

STORAGE AND HANDLING SECTION

Store At Or Below 25°C (77°F), Excursions Permitted Up To 40°C (104°F)

SPL UNCLASSIFIED SECTION

Not For Human Use

Restricted Drug (California) – Use Only As Directed

Net Weight 450 lb (204.12 kg)

Bloat Guard is a registered trademark of Phibro Animal Health Corporation for poloxalene

Phibro Animal Health, Inc., Teaneck, NJ 07666

Approved by FDA under NADA #038-281

8816000

101-8031-07

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BloatGuard Liquid-07
BloatGuard Liquid-07

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66104-8816-0Bloat Guard204.12 kg in 1 CONTAINERLIQUID204.127

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66104-8816BLOAT GUARD (POLOXALENE) LIQUID [PHIBRO ANIMAL HEALTH]71 package rows20190702_e1af9ef3-c30d-4c9b-930e-49213621ec73.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
POLOXALENEACTIVE INGREDIENTV8B3K56SW03
POLOXALENEACTIVE MOIETYV8B3K56SW03
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K3
ETHOXYQUININACTIVE INGREDIENT9T1410R4OR3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
66104-881666104-8816-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 32 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSPRAY / TOPICAL3 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSWAB / TOPICAL0.5 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSOLUTION / ORAL14 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, POWDER, FOR SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KFILM, SOLUBLE / ORAL0.06 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCAPSULE, LIQUID FILLED / ORAL0.1 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCREAM, AUGMENTED / TOPICAL0.2 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KLOTION / TOPICAL1000 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KAEROSOL, FOAM / TOPICAL4 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KGEL / TOPICAL8 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KOINTMENT / TOPICAL57 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET / ORAL3 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCREAM / VAGINAL0.05 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS0.02 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KGEL, METERED / TOPICAL4 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSOAP / TOPICAL0.02 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCREAM / TOPICAL6 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSUPPOSITORY / VAGINALNAExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCAPSULE, EXTENDED RELEASE / ORAL0.03 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCAPSULE / ORAL3 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSOLUTION, CONCENTRATE / ORAL0.1 mg/1mlExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSOLUTION / TOPICAL3 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KGUM, CHEWING / BUCCAL5 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSUPPOSITORY / RECTAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET / SUBLINGUAL0.13 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, FOR SUSPENSION / ORAL0.1 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSHAMPOO / TOPICAL0.1 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSPRAY, METERED / NASAL0.1 mg/1mlExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.